Coverage
-
January 02, 2014
Advanced Cell Technology Inc. on Monday agreed to pay $4.1 million to resolve allegations by the U.S. Securities and Exchange Commission that the biotechnology firm issued unregistered penny stocks through sham legal settlements in a long-running scheme.
1 other articles on this case.
View all »